Objectives/Hypothesis: In children with ventilation tubes (VTs) inserted for chronic otitis media with effusion (COME), the authors sought to determine whether any parameter of Eustachian tube (ET) function measured by the forced response test (FRT) predicts disease recurrence after the VT becomes nonfunctional.
INTRODUCTION
The middle ear (ME) is a relatively noncollapsible biological gas cavity that must be maintained at near ambient pressures.
1 However, ME-ambient pressure equivalence is unstable, being perturbed by changes in atmospheric pressure and by the progressive decrease in ME pressure due to passive diffusive nitrogen exchange between the ME and local mucosal blood.
1 The Eustachian tube (ET) represents a potential communication between the ME airspace and the nasopharynx. 2 Whereas the lumen of the ET is usually closed, the normally functioning ET is opened intermittently by active tensor veli palatini muscle (mTVP) contraction during swallowing and other activities 3 to allow gradient-driven gas transfer between the nasopharynx and ME, thereby lessening any extant ME-ambient pressure gradients. In animals, failure of the ET to open causes the progressive development of ME underpressure that at 2200 to 2300 daPa (relative to ambient pressure) provokes ME mucosal inflammation, capillary disruption, and transudation of fluid from the local blood to the ME, a disease presentation similar to that of otitis media with effusion (OME). 4 Other studies in monkeys show that the disease resolves in concert with the reacquisition of mTVP-assisted ET dilation. 5 In infants, children, and adults with ventilation tubes (VTs) inserted into their tympanic membranes as a treatment for chronic OME (COME), ET function (ETF) tests usually document a severely limited transfer of gas between the ME and nasopharynx during activities associated with mTVP activity. [6] [7] [8] [9] Alternatively, other studies reported an association between COME and the ability to change ME pressure with forcible sniffing, a condition indicating incomplete closure of the ET lumen in COME patients. 10, 11 Although these results support an association between ET dysfunction and COME, it is unclear whether the poor ETF is the cause or consequence of COME.
The present study was designed to clarify the directionality of the cause-effect relationship by determining whether the results of ETF testing in children with VTs inserted for COME can predict disease recurrence after the VTs become nonfunctional. We tested ETF using a modification of the forced response test (FRT) that captures information on the magnitude of the pressures closing the ET lumen and on the magnitude of mTVPassisted active ET openings. 12 The advantages of using the FRT in young children are the relatively short duration of the procedure and the limited participation required of the test subject. 8, 9 Our primary hypothesis was that inefficient mTVP-assisted ET opening is a robust predictor of disease recurrence during the follow-up period.
MATERIALS AND METHODS
We prospectively enrolled children aged 3 to 6 years with VTs inserted for COME in a two-stage study: documentation of ETF while VTs were functional and documentation of disease recurrence after the VTs became nonfunctional. All children were enrolled within 6 weeks after VT insertion for COME (defined as 3 months bilateral ME effusion, 6 months unilateral ME effusion, 3 episodes of OME during the previous year, or recurrence of OME after extrusion of previous VTs for OME). Children were excluded if they had cleft palate or other syndromes predisposing to otitis media or a history of complications of otitis media or its treatment, or were unable to cooperate during testing. The study was approved by the institutional review board of the University of Pittsburgh, and written informed consent was obtained from a parent before enrolling each child in the study.
FRTs were scheduled at 3-month intervals while the VTs were patent. The number of FRT sessions varied among ears (depending upon length of time of VT patency, child cooperation, and other factors). For purposes of this analysis, we used the results for the last, most complete test done when the child was free of a cold (closest to the time of VT nonfunctionality). After each VT became nonfunctional, the ear was followed monthly for ME status by pneumatic otoscopy and tympanometry for up to 12 months or until ME effusion was observed in the same ear on three consecutive visits. We then assigned each ear to one of three groups: group I 5 little to no ME disease on follow-up (no otitis media or 1-2 visits with otitis media), group II 5 ME effusion diagnosed at three consecutive visits during follow-up, and group III 5 ears that could not be assigned to either group I or group II for any of a variety of reasons. For our analysis, we focused on those ears with an unambiguous post-VT disease assignment (groups I and II).
ETF was measured in each ear with a patent VT using a modification of the FRT originally described by Cantekin and colleagues. 12 Briefly, a hermetically sealed probe was introduced into the ear canal ipsilateral to the ET being evaluated. The probe was coupled to a flow sensor, pressure transducer, and via a valve to a constant flow pump. For testing, the pump delivered approximately 23 mL/min (QO) of airflow to the ME. This caused the ME pressure to increase and the ET to passively open at a measured pressure (opening pressure). Continued delivery of airflow resulted in a semistable system pressure (PS) at a trans-ET airflow (QS) approximately equal to QO. The child was instructed or induced to swallow, an action associated with mTVP contraction, and the preswallow system pressure (PA) and maximum trans-ET airflow during the swallow (QA) were recorded. The pump was turned off allowing the ET to passively close while retaining a residual ME pressure (closing pressure). The test was then repeated for the contralateral ET using an identical procedure. These data were processed to calculate the active (CA 5 QA/PA) and passive (CS 5 QS/PS) conductances, which are measures of the airflow through the ET during mTVP contraction and under basal conditions, respectively. We then calculated the mTVP dilatory efficiency as the active/passive conductance ratio (CA/CS), which measures the fold increase (or decrease) in trans-ET airflow during mTVP contraction. The FRT parameters analyzed for this report included the opening pressure, which measures the summed extra-and intraluminal forces acting to maintain a closed ET lumen, the closing pressure, which measures the periluminal pressure acting to close the ET lumen, and the dilatory efficiency, which measures the efficiency of active, mTVP-assisted tubal dilation.
Analyses of the pressure flow waveforms for each test were done by each of two technicians, and the resulting data were compared and reconciled prior to entry into the database. To analyze these data, we used a series of logistic regression models to determine whether the included factors predicted disease recurrence during the follow-up period after the VTs became nonfunctional. Our first models operated on all ears that achieved a study endpoint and included as candidate predictors of disease recurrence the opening pressure, closing pressure, and dilatory efficiency without and then with selected demographic and historical characteristics for each subject. The sample size constrained the number of characteristics that could be included in the model, and therefore we chose a subset representing those with the greatest potential to affect disease recurrence. This set included age, sex, race, the number of past VT insertions, the duration of VT patency, and whether the child had a previous adenoidectomy, an adenoidectomy with VT insertion at the time of entry, or no adenoidectomy. Also, we recognize that in subjects with two evaluable ears (bilateral cases), the left and right ears may not be independent observations. Therefore, we reran the full logistic regression model while limiting the data to the ears of subjects with one evaluable ear (unilateral) and the right ears of bilateral cases and then all unilateral ears and the left ears of bilateral cases. Finally, we recognize that group I was not homogenous in that ears with no evidence of disease recurrence were combined with those that had 1 or 2 months of otitis media on the assumption that any short-duration otitis media episode represented the consequences of a recent cold (or allergy) and did not reflect a recurrence of COME by usual definitions. However, this introduced a new variable into the analysis, and therefore we eliminated those ears with one or two visits with otitis media and reran the complete logistic regression model. Data were analyzed using the NCSS Statistical Package (NCSS Statistical Software, Kaysville, UT). We used the cutoff of 0.05 to assign statistical significance.
RESULTS
Eighty-four children with bilateral VTs were entered; 33 children were withdrawn by their parents or investigators or discontinued follow-up before reaching an endpoint in either ear. Of the remaining 51 subjects with evaluable outcomes, two subjects had a clinical course not defined by either group I or group II and were excluded from the analysis.
Classification as either group I or group II was done for 73 ears in 49 children (25 with one ear evaluable, 24 with both ears evaluable). Summary data for the demographic and historical characteristics of these 49 subjects are shown in Table I . For those 25 subjects with only one ear evaluable, the status of the contralateral ear was as follows: eight had a VT or perforation at end of follow-up, 12 had not achieved a study endpoint, and five were not classifiable as either group I or group II. Of the 73 ears included in the analysis, 44 were classified as group I (no otitis media [n 5 21] or 1-2 visits with otitis media [n 5 23]), and 29 were classified as group II.
In an initial screening of the data, we compared the relevant summary parameter for each of the characteristics listed in Table I between groups using either Fisher exact test (for dichotomous variables) or Student t test (for continuous variables). The only significant betweengroup differences were in the sex (P 5.02) and race (P 5.03) distributions for the groups.
Summary data for the three FRT parameters and for the subject characteristics included in the subset of tested predictors are reported in Table II for each group. The simple logistic regression model that included only the FRT variables as possible predictors identified dilatory efficiency but not the ET opening (P 5.84) or closing (P 5.57) pressures as a significant predictor of disease recurrence (beta coefficient 5 20.49, Z value 5 22.64, P 5.01).
A summary of the logistic regression analyses for the complete model that included the FRT parameters and the subject characteristics within the subset is presented in Table III . The r 2 for the complete model (model 1) was 0.50. Low dilatory efficiency, short VT duration, being male, and being nonwhite were significant predictors of a greater risk of disease recurrence. For the models operating on the single ear data subsets (models II and III), the r 2 was 0.49 for unilateral ears and the right ears of the bilateral cases and 0.63 for unilateral ears and the left ears of bilateral cases. For both models, the duration of VT patency and the dilatory efficiency were retained as significant predictors of COME recurrence, but race and gender were no longer significant, most probably reflecting the loss in statistical power associated with the lesser sample sizes for these models. For the model that controlled for the heterogeneity of group I ears by restricting group membership to ears with no evidence of otitis media during the follow-up period, the 
DISCUSSION
The goal of the present study was to test the hypothesis that a parameter of the FRT is a significant predictor of disease recurrence in children with COME during the 12-month period after the VTs inserted for that condition became nonfunctional. The results for the simple and more complex logistic regression analyses performed on the study data support this hypothesis, indicating that dilatory efficiency, a measure of the efficiency of mTVP-assisted ET opening, was a significant predictor of group assignment, with lower dilatory efficiencies associated with disease recurrence. However, isolating dilatory efficiency as the single predictor for disease recurrence in a limited regression model had an r 2 of 0.15 and correctly assigned 77% of the group II (recurrence) ears but only 45% of the group I ears. These results show that dilatory efficiency is not sufficiently specific or sensitive to be used alone in the clinical setting for predicting the presence or absence of disease recurrence in individual patients with VTs inserted for COME. Nonetheless, our analyses convincingly demonstrate a role for inefficient muscle-assisted ET opening in the pathogenesis and recurrence of COME in children.
The FRT is one of a number of ETF tests currently in use. Most of these include a parameter that, like FRT dilatory efficiency, reflects the efficiency of muscleassisted ET openings. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] It is not known whether these parameters are more or less predictive of disease recurrence in children with COME after their VTs are extruded than dilatory efficiency, but this possibility should be explored in future studies. It may be possible, and perhaps expected, that combining the results for tests that capture different dimensions of mTVP-assisted ET opening will increase the specificity and sensitivity for identifying patients at risk for disease recurrence to clinically useful levels.
Because the FRT is almost exclusively used in our laboratories, and until recently our primary focus was on the study of ETF in animal models of COME, 4,5 the underlying factors that contribute to the intra-and inter-ear variability in dilatory efficiency have not been explored. However, for other tests of ETF, both situational and constitutional factors were shown to influence their respective measures of muscle-assisted ET opening, and we would expect the same to hold true for dilatory efficiency. Of the former, the most well documented is nasal inflammation caused by either upper respiratory virus infection, allergy, or sinusitis, which was shown to decrease the efficiency of muscle-assisted tubal openings by blocking the nasopharyngeal orifice of the ET and/or by extension of the inflammation to the ET mucosa. 8, 17, [23] [24] [25] In the present study, we did not test children when a cold-like illness was present, and too few children were diagnosed with nasal allergy to determine whether this known effect for other measures of ET opening function characterizes dilatory efficiency. The best supported constitutional factor is the extant degree of maturation of the ET system. For example, when compared to older children and adults, young children are characterized by poorer muscle-assisted ET openings, 15 the mTVP cross-sectional area is much smaller, and the vector relationship between the mTVP muscle and the ET is less efficient. 26 This is an active area of current study by our group; we are mapping the change in ETF as measured by the FRT onto the changes in the anatomy of the ET-ME system during growth and development. A large number of other factors have been suggested to affect mTVP-assisted tubal opening, but these remain largely hypothetical and without support in humans. For example, the possibility of a myogenic origin for poor mTVP function has been revisited over the years, but this condition appears to be extremely rare, and when present is related to nasopharyngeal tumors invading the mTVP or its nerve. 14, 27, 28 Similarly, intraluminal surfactants are expected to improve ET opening efficiency, but there is little evidence from studies in humans to support this contention. 29 The full logistic regression model identified four factors that predict COME recurrence: low dilatory efficiency, a short duration of time with a patent VT, male gender, and nonwhite race. The inclusion of these four factors in the regression model correctly assigned 82% of the group II ears and 72% of the group I ears, a sensitivity and specificity that approach values with clinical utility.
In retrospective studies, a longer time of VTs remaining patent was associated with a lower frequency of otitis media recurrence after the VTs became nonfunctional. Ahn and colleagues 30 reviewed the medical records of 423 children who underwent VT insertion for COME and compared the duration of VT function between those who had undergone one VT procedure and those who had undergone three VT procedures. Mean "tube life" in the singleoperation group was 13.6 months versus 9.9 months in the three-operation group. Yaman and colleagues 31 reviewed a case series of 91 children with COME, and reported that the highest rate of disease recurrence was in the group with the shortest time to VT extrusion; recurrence rates of 36.5%, 17.7%, and 9.1% were observed in groups with VT patency for <6 months, 6 to 12 months, and >12 months, respectively. These results support our findings and may reflect the relatively long period with an effusion-free ME required for mucosal healing within the tympanum and the mastoid during COME as previously reported [32] [33] [34] or that the disease process underlying COME (e.g., inflammation, allergy) also contributes to early tube extrusion/ nonfunctionality. From our general model, but not the submodels, males were more likely to have disease recurrence than females. This is not supported in the literature, where studies by Ahn and colleagues, Yaman and colleagues, and Boston and colleagues found no difference between males and females in disease recurrence. 30, 31, 35 However, these negative findings were reported for retrospective studies that did not control for potentially interactive factors or include the tightly scheduled, close prospective follow-up for recurrence used in the present study. For these reasons, the potential significance of our observation of a gender effect, if any, will need to await the results of future studies.
Our model identified nonwhite race as a risk factor for disease recurrence after VT extrusion, but there are few existing data to support or refute this observation. One suggestive retrospective review done by Boston and colleagues reported a greater number of VT insertions in whites, but their logistic model did not identify race as a contributing factor. 35 Again, our results on a racial effect must await future studies for confirmation or refutation.
Three retrospective studies reported that compared to VT insertion alone, adenoidectomy performed with VT insertion was associated with fewer later VT reinsertions. [35] [36] [37] Randomized studies by Maw and Bawden of children aged 2 to 11 years with COME 38 and by Gates and colleagues of children aged 4 to 8 years with COME 39 reported more favorable outcomes with respect to long-term disease resolution for groups treated with adenoidectomy and VT insertion when compared to VT insertion alone. In contrast, more recent randomized studies in younger children aged 12 to 48 months with recurrent acute otitis media or COME 40 or in children aged 24 to 47 months with COME 41 failed to document an increased benefit of adenoidectomy and VT insertion when compared to VT insertion alone. In the present study, we included within the regression model a variable representing no history of adenoidectomy, a past history of adenoidectomy, or adenoidectomy concurrent with the VT insertion for the study endpoint. That variable was not a significant predictor of disease recurrence.
CONCLUSION
The results of the present study identified two robust predictors of COME recurrence after VTs inserted for COME in children are extruded: the length of time that the VT was patent and a measure of active, mTVP-assisted ET opening, the ET dilatory efficiency. Minor factors whose significance was lost for restrictive data sets were being male and being nonwhite, and both were positive predictors of disease recurrence. Adenoidectomy at the time of VT insertion or previous adenoidectomy, number of previous VTs inserted, the child's age at entry, and the ET opening and closing pressures were not significant predictors of disease recurrence. A limitation of the present study is the relatively small sample size, which may have decreased our ability to detect significant predictors. Our finding that dilatory efficiency is a predictor of COME recurrence should be tested in other cohorts and for prediction of other disease outcomes to establish whether this ETF parameter has applications in the clinical setting.
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